|
|
Volumn 28, Issue 3-4, 2002, Pages 493-500
|
|
Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC
|
|
Author keywords
Celecoxib; Dosage form; MEKC; R.S.D.; Stability; Validation
|
|
Indexed keywords
2 NITROANILINE;
ANILINE DERIVATIVE;
BORIC ACID;
BUFFER;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
DODECYL SULFATE SODIUM;
REVIBRA;
UNCLASSIFIED DRUG;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
CALIBRATION;
COMMERCIAL PHENOMENA;
CORRELATION FUNCTION;
DRUG DETERMINATION;
DRUG DOSAGE FORM;
MICELLAR ELECTROKINETIC CHROMATOGRAPHY;
MIGRATION;
PH;
PRIORITY JOURNAL;
REPRODUCIBILITY;
STANDARD;
TEMPERATURE;
TIME;
VALIDATION PROCESS;
ANILINE COMPOUNDS;
BUFFERS;
CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
HYDROGEN-ION CONCENTRATION;
INDICATORS AND REAGENTS;
ISOENZYMES;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
SODIUM DODECYL SULFATE;
SULFONAMIDES;
|
|
EID: 0037093765
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/S0731-7085(01)00670-7 Document Type: Article |
|
Times cited : (29)
|
|
References (9)
|
